Flat-of-the-curve medicine: a new perspective on the production of health
Open Access
- 20 July 2011
- journal article
- Published by Springer Nature in Health Economics Review
- Vol. 1 (1) , 2
Abstract
Health economists have studied the determinants of the expected value of health status as a function of medical and non-medical inputs, often finding small marginal effects of the former. However, medical inputs may have an additional benefit in the form of a reduced variability of health status. Using the standard deviation of life expectancy in 24 OECD countries between 1960 and 2005, a 10 percent increase of health care expenditure is associated with a decrease of an estimated 0.42 percent. Willingness to pay for such a reduction of uncertainty may well exceed the extra health care expenditure in the United States and Switzerland. This implies that even in these two countries with very high health care expenditure per capita, flat-of-the-curve medicine need not be wasteful.Keywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Mortality InequalityJournal of Economic Perspectives, 2009
- The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level DataAmerican Economic Review, 2007
- The Value of Health and LongevityJournal of Political Economy, 2006
- The Determinants of Life Expectancy: An Analysis of the OECD Health DataSouthern Economic Journal, 2005
- More Variation In Use Of Care, More Flat-Of-The-Curve MedicineHealth Affairs, 2004
- Gini coefficient as a life table functionDemographic Research, 2003
- Is Technological Change In Medicine Worth It?Health Affairs, 2001
- Inequality Decomposition Analysis and the Gini Coefficient RevisitedThe Economic Journal, 1993
- Conversion factor instability in international comparisons of health care expenditureJournal of Health Economics, 1991
- Aging, Natural Death, and the Compression of MorbidityNew England Journal of Medicine, 1980